Enrollment
Recruitment started in May 2017 and was completed in January 2023. During this period 965 patients were randomized to the S-ICD implant with DFT or S-ICD implant without DFT.
Duration of the study
The study will be completed at a median follow-up of 40 month.
Participating centers
Patients are randomized in centers in Europe, the United States of America and Asia. All centers have qualified cardiology departments with facilities for ICD implantation and have ample experience with S-ICD implantation and DFT testing. Follow up visits are performed under routine protocols.
Results
Results of the study were presented as a late breaking clinical trial at the Heart Rhythm Society (HRS) 2026 conference. The presentation is available here. The data are published in Circulation.
The PRAETORIAN-DFT trial is registered with ClinicalTrials.gov (NCT03495297).